Welcome to the Idaho Chapter of the American College of Cardiology
| Alina Robert, MD, FACC
Chapter President
|
| Robert Duerr, MD, FACC
Incoming Governor
|
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.
Latest in Cardiology from ACC.org
- FXN Gene Therapy Shows Promise in Treating Patients With FA CardiomyopathyIn patients with Friedreich ataxia (FA) cardiomyopathy, intravenous administration of AAVrh.10hFXN, an rh.10 serotype cardiotropic adenoassociated virus vector expressing the normal human FXN coding sequence, was well tolerated and showed promise as a potential treatment...
- Resistance Training Associated With Lower Risk of T2D in US AdultsConsistent resistance training (RT) may be an important component of type 2 diabetes (T2D) prevention recommendations, especially when combined with adequate aerobic activity and limited sedentary behavior, according to a prospective cohort study published June 22 in JAMA.
- Eagle’s Eye View: Can Resistance Training Lower CV Risk?In this week’s View, Dr. Eagle reviews 21-year follow-up data from the Diabetes Prevention Program (DPP), showing that lifestyle intervention—but not metformin—reduces multimorbidity risk in prediabetes.
- Single vs. Double TSP in AFib Ablation Yields Comparable Outcomes | NCDR StudyAmong patients undergoing atrial fibrillation (AFib) ablation, single and double transeptal puncture (TSP) exhibited similar procedural safety and likelihood of discharge in sinus rhythm, according to a recent study published in the Journal of Interventional Cardiac Electrophysiology.
- Genotype Independently Predicts HF Outcomes in Patients With HCMIn patients with hypertrophic cardiomyopathy (HCM), genotype, peak VO2, log NT-proBNP and LVEF independently predict heart failure (HF) outcomes, and combining these measures identified patients at higher risk of HF-related death or transplant, according to a recent study published in JACC: Heart Failure.